ASHPOfficial

Learn from experts on compliance with USP Chapter <797> in all size facilities. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us as members of the 2023-2024 ASHP Pharmacy Technician Forum Executive Committee share their journey into leadership at the state and national level. Listen as we explore personal growth and professional insights gained through active involvement in professional associations. Discover how you too can make a meaningful impact. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, the team from the Henry Ford Health System to discuss their award winning submission to the ASHP Best Practices. They will share how the addition of a pharmacist to the multidisciplinary interstitial lung disease (ILD) team, along with the robust collaboration with a specialty pharmacy, improved the quality of patient care in ILD and generated significant revenue for their health system. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast provides an interview with one of the first pharmacist hospital CEOs, Bill Evans, retired CEO of St. Jude Children’s Research Hospital, and one of the first health system Vice Presidents of Pharmacy and author of the 2005 AJHP paper “Rationale for having a chief pharmacy officer in a health care organization”, Marianne Ivey. They will explore the evolution of pharmacy executives and the path of pharmacy practice and the opportunities still ahead. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will focus on how generative artificial intelligence (AI) impacts administrative aspects of pharmacy practice. We will focus on current technologies and future applications of generative AI in this space. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership Episode, Tyler Darcy sits down with the Pharmacy Technician Forum Awardee Julia Becker to discuss what membership within the forum and ASHP means to her and how it has helped her develop as a pharmacy practice leader. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast aims to explore what health disparity and equity is, examine their connection to Pharmacoequity and discuss how the P&T committee can address these issues within the formulary review process. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts in the field on the current status and future of COVID-19. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The US Food and Drug Administration (FDA) implemented Risk Evaluation and Mitigation Strategy (REMS) programs to ensure benefits outweigh the safety risks of particular medications. With over 60 medications with REMS programs and varying requirements for each, operationalizing to comply with requirements can be challenging. In this podcast, we talk about some of those challenges and how to operationalize recommendations for those who routinely see these medications in practice, as well as for those who come across them sporadically. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership Episode, Benjamin Anderson, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with SOPIT member and Distinguished Service Awardee for 2023, Maritza Lew, to discuss her service within the section and the role ASHP has played in her development as a pharmacy practice leader. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast explores pharmacists’ perceptions of incorporating telehealth and opportunities to improve its development in clinical practice. The purpose of this discussion is to uncover the optimal potential of telehealth and learn about key insights of this modernized practice. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, Specialty Pharmacy leaders will discuss how to review a payer contract, keys elements to address, and strategies to negotiate a favorable contract. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician. Any legal information included in this podcast is for our listeners' educational purposes only. It is not intended as legal advice. If you have specific legal questions, you should contact the legal department of your organization or outside counsel.

ASHP Official hosts Amy Gutierrez for a discussion about a unique session planned for the ASHP Pharmacy Futures focused on pharmacist recruitment and retention strategies. Pharmacist Personnel Puzzle: Key Insights into Workforce Recruitment and Achieving Results will feature Amy and two additional experts and provide actionable takeaways specifically crafted for pharmacy leaders by pharmacy leaders. This session is eligible for live CPEL recertification credit. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP Official welcomes Sara Stallworth and Timothy Aungst for a lively discussion about a session they collaborated on for the inaugural ASHP Pharmacy Futures in Portland. Using the future focused theme of AI, Navigating the Future: AI, Digital Health, and Technology in Pharmacy Precepting, Sara and Tim have creatively designed strategies for preceptors to engage with learners using technology, and provide background knowledge for preceptors to guide safe use and adoption of new platforms in their experiential learning plans. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we’ll be reviewing the presentation of varicella zoster virus, the epidemiology and disease burden of herpes zoster and identifying interventions to reduce the incidence of Herpes Zosters and its complications. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

UCSF data scientist and pharmacist Ben Michaels joins ASHP official for an overview of the exciting AI Summit content planned for the inaugural Pharmacy Futures meeting in Portland. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast, hosted by the New Practitioners Forum, features Melanie Dodd, Chair of ASHP House of Delegates, and focuses on advocating for pharmacy within and outside the profession. Dr. Dodd shares her perspectives on her role, professional advocacy, and the impact of the ASHP House of Delegates. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Members of Congress are increasingly focused on addressing drug shortages. Tom Kraus and Michael Ganio discuss a new bipartisan proposal that would use payment incentives to shift purchasing behavior to mitigate drug shortages. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP official hosts Accreditation services staff members Andrea Haron and Michelle McCarthy as they share expert insights on preceptor focused programming that will be available in June at the newly designed ASHP Pharmacy Futures meeting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP Official is joined by their very own Mike Ganio, Senior Director of Practice and Quality, for insightful discussion about the sterile compounding education that will be showcased at the very first Pharmacy Futures meeting including the unique hands-on competency training designed for Designated Persons. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will highlight the role of the Medication Safety Officer, the varied pathways toward the role, and current challenges that are top of mind. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast features a conversation about engaging the next generation of pharmacy leaders. As current health-system pharmacy leaders, the participants hope to discuss tools and strategies being used to foster leadership skills and develop an interest for emerging leaders in their organizations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide members an overview of the Inflation Reduction Act’s drug pricing provision. We’ll cover the negotiated pricing, drug rebates, and what all of these changes will mean for you. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP National meetings team education director Cynthia von Heeringen joins clinical faculty experts Kristi Kelley and Morgan Stewart to discuss their upcoming session at the Pharmacy Futures meeting. More Than "Equal": Navigating the Changing Landscape of Diabetes Care to Promote Care Equity highlights the unique position pharmacists are in to promote wellness and break down barriers to care access for patients beyond the clinical guidelines for disease management. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, the team from the Atrium Health System discuss their award-winning submission to the ASHP Best Practices. They will share how their program implemented a novel pharmacist-led DPYD testing program with CDS integration and demonstrated pre-treatment testing with genotype-guided fluoropyrimidine dosing improves patient safety by mitigating severe toxicities and hospitalizations in DPYD variant carriers. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP National Meetings team education director Cynthia von Heeringen joins faculty member and licensed clinical social worker Kristy de Vries from Nationwide Children’s Hospital to discuss the upcoming Pharmacy Futures workshop on Second Victim Program Implementation. This half day program is included with registration and will provide attendees with background knowledge and skills to provide second victim support as well as a strategic toolkit to implement a second victims support program at their own facility. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode of the series will provide an overview of the history of Polio, eradication, and the effect of vaccination on global health. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Eliana Abboudi and Dr. Emily Messing discuss the AJHP Practice Research Report, “Pharmacy-driven performance improvement initiative to increase compliance with intravenous smart pump drug error reduction systems at a large urban academic medical center,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

From streamlining medication management to enhancing patient care, artificial intelligence has the potential to transform the way pharmacists practice. In the first of a three-part series, this podcast will lay the foundation of knowledge for what artificial intelligence is and how it is being utilized within the profession of pharmacy and pharmacy education. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership Episode, Christi Jen, sits down with the Section of Clinical Specialists and Scientists Awardee Rena Gosser to discuss what membership within the Section and ASHP means to him and how it has helped him develop as a pharmacy practice leader. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts in the field on the current status and future of COVID-19. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join a discussion between two trailblazing pharmacy practice researchers on the value of pharmacist researchers, how a PharmD graduate can start doing research, and how to maintain it over a career. Kevin Garey, the 2023 recipient of the ASHP Foundation Award for Sustained Contributions will be sharing his secrets of success with C. Michael White, a past awardee and chair of the ASHP Foundation Research Advisory Council. Whether you are just starting out or are mid-career in research, this podcast is for you! The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast delves into effective strategies tailored for new practitioners stepping into leadership positions, like residency program leadership or clinical coordination, where they must manage and teach individuals with greater experience. It emphasizes the delicate balance of integrating fresh ideas while respecting existing practices, recognizing that learning is a continuous journey for everyone involved. The discussion underscores the importance of remaining open to new ideas from team members and embracing a mindset of acknowledging one's limitations to navigate potential challenges successfully. Drawing from the insights of experienced leaders from the SCSS Clinical Leadership SAG, listeners gain practical advice and valuable insights into thriving in such leadership roles. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast, hosted by the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), is intended to give new and upcoming pharmacy leaders and managers tips for navigating upcoming job interviews post-residency. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts on compliance with USP Chapter <797> in small and rural hospitals. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In November 2021, Arkansas enacted a law, known as Act 1103, that prohibited drugmakers from placing restrictions on 340B contract pharmacies and child sites. The Pharmaceutical Research and Manufacturers of America (PhRMA) immediately filed suit to block implementation of Act 1103, delaying enforcement of the law for nearly 2 years. However, on March 12, 2024, the U.S. Court of Appeals for the Eighth Circuit rejected PhRMA’s arguments and ruled Act 1103 is valid and enforceable. In the podcast, we talk about the implications of the ruling for the broader 340B program and covered entities nationwide. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, members of the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) discuss strategies and advice to help future residents navigate the post-match process. Speakers highlight important steps that newly-matched residents can take to set themselves up for a successful transition into their residency positions. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Recent trends indicate the GLP-1 market will exceed $100 billion by 2030; this is not a surprise for the health care system as discussion and use of these medications within this class has continued to soar. As the prescribing of these medications continue to increase, pharmacists in all settings must be well versed to ensure they are able to provide appropriate counseling, education, and adjustments for patients and provide clinical insight to the healthcare team. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we will be discussing development and implementation of a collaborative practice agreement within an integrated health system specialty pharmacy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership episode, Sarah Stephens sits down with the Section of Inpatient Care Practitioners 2023 Distinguished Service Awardee, Lois Parker, to discuss what membership within the section and ASHP means to her and how it helped her develop as a pharmacy practice leader during her career. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Respiratory syncytial virus is a viral illness that usually causes mild, cold-like symptoms. RSV vaccine can help prevent lower respiratory tract disease caused by RSV. This podcast will discuss the use of the RSV vaccine in adults and pregnancy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join the ASHP Pharmacy Administration and Leadership Residents’ Collaborative (PALRC) for a candid conversation among pharmacy administration and leadership residents as they discuss how meaningful connections can propel you towards your next professional milestones and reshape your approach to success. Let the shared experiences and invaluable guidance of our guests inspire next steps in your career journey in this captivating exploration of what lies ahead in the world of possibilities. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

4 recipients of the 2023 ASHP Foundation Literature Awardees discuss their projects and approaches to pharmacy research. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The National Institute for Occupational Safety and Health (NIOSH) is the federal research institute focused on the study of worker safety and health and empowering employers and workers to create safe and healthy workplaces, and the Dr. Lorna Breen Heroes’ Foundation is the only nonprofit organization exclusively focused on healthcare worker mental health and well-being. NIOSH and the Dr. Lorna Breen Heroes’ Foundation recently released the Impact Wellbeing Guide, which provides hospital leadership with step-by-step guidance to make operational changes that improve healthcare worker wellbeing within their hospitals. In this podcast, we will discuss the Guide and its resources, as well as how hospital leaders can use it to build a system where pharmacists – and all healthcare workers – thrive. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Lindsay Bowman, Dr. Olivia Berger, and Dr. Suzanne Nesbit discuss the AJHP Descriptive Report, “Operationalizing the new DEA exception: A novel process for dispensing of methadone for opioid use disorder at discharge from acute care settings,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership Episode, Justin Moore, Chair of the New Practitioners Forum (NPF) Executive Committee, sits down with the 2023 NPF Distinguished Service Awardee, Joe Marchiano, to discuss what membership within the Forum and ASHP means to him and how it has helped him develop as a pharmacy practice leader. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts in the field on optimizing PARP inhibitor outcomes in cancer therapy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join experts as they discuss similarities and differences between improvement and implementation science and how to incorporate rigor in projects to expand dissemination opportunities and practice change. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Recent trends indicate the GLP-1 market will exceed $100 billion by 2030; this is not a surprise for the health care system as discussion and use of these medications within this class has continued to soar. As the prescribing of these medications continue to increase, pharmacists in all settings must be well versed to ensure they are able to provide appropriate counseling, education, and adjustments for patients and provide clinical insight to the healthcare team. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will provide members an overview of the impact of CMS audit practices on pharmacy residency programs. We’ll cover the challenges audits have created, how programs can prepare and protect themselves, and ongoing ASHP advocacy efforts to protect these programs. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.